Two Sigma Investments’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,638
| Closed | -$224K | – | 3411 |
|
|
2024
Q4 | $224K | Sell |
9,638
-165
| -2% | -$3.84K | ﹤0.01% | 2777 |
|
|
2024
Q3 | $288K | Sell |
9,803
-39
| -0.4% | -$1.15K | ﹤0.01% | 2620 |
|
|
2024
Q2 | $231K | Sell |
9,842
-3,513
| -26% | -$82.6K | ﹤0.01% | 2612 |
|
|
2024
Q1 | $507K | Sell |
13,355
-14,740
| -52% | -$559K | ﹤0.01% | 2264 |
|
|
2023
Q4 | $605K | Buy |
+28,095
| New | +$605K | ﹤0.01% | 2281 |
|
|
2023
Q2 | – | Sell |
-12,820
| Closed | -$92.9K | – | 3170 |
|
|
2023
Q1 | $92.9K | Sell |
12,820
-2,926
| -19% | -$21.2K | ﹤0.01% | 2605 |
|
|
2022
Q4 | $177K | Buy |
15,746
+11,602
| +280% | +$130K | ﹤0.01% | 2359 |
|
|
2022
Q3 | $54K | Sell |
4,144
-8,490
| -67% | -$111K | ﹤0.01% | 2260 |
|
|
2022
Q2 | $160K | Buy |
12,634
+3,970
| +46% | +$50.3K | ﹤0.01% | 2137 |
|
|
2022
Q1 | $498K | Buy |
8,664
+6,084
| +236% | +$350K | ﹤0.01% | 1975 |
|
|
2021
Q4 | $306K | Buy |
+2,580
| New | +$306K | ﹤0.01% | 2160 |
|
|
2021
Q2 | – | Sell |
-733
| Closed | -$145K | – | 2869 |
|
|
2021
Q1 | $145K | Sell |
733
-1,838
| -71% | -$364K | ﹤0.01% | 2204 |
|
|
2020
Q4 | $506K | Sell |
2,571
-3,060
| -54% | -$602K | ﹤0.01% | 1589 |
|
|
2020
Q3 | $998K | Buy |
5,631
+2,334
| +71% | +$414K | ﹤0.01% | 1173 |
|
|
2020
Q2 | $762K | Buy |
3,297
+1,880
| +133% | +$435K | ﹤0.01% | 1255 |
|
|
2020
Q1 | $165K | Sell |
1,417
-568
| -29% | -$66.1K | ﹤0.01% | 1644 |
|
|
2019
Q4 | $379K | Buy |
+1,985
| New | +$379K | ﹤0.01% | 1793 |
|
|
2019
Q3 | – | Sell |
-1,978
| Closed | -$339K | – | 2336 |
|
|
2019
Q2 | $339K | Buy |
+1,978
| New | +$339K | ﹤0.01% | 1715 |
|
|
2018
Q4 | – | Sell |
-1,055
| Closed | -$252K | – | 2419 |
|
|
2018
Q3 | $252K | Buy |
1,055
+574
| +119% | +$137K | ﹤0.01% | 1799 |
|
|
2018
Q2 | $127K | Buy |
+481
| New | +$127K | ﹤0.01% | 1927 |
|